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Abstract 
Background: Although there are several diseases that cause erythroderma, patients are 
often encountered with erythroderma of unknown cause which persists for a long time. 
The aim of this study was to characterize this chronic idiopathic erythroderma (CIE).  
Methods: Adult patients with CIE, atopic dermatitis (AD), psoriatic erythroderma (PsE), 
or generalized drug eruption (DE), who visited Fukuoka University Hospital 
Dermatology Department from 2010 to 2015, were enrolled. Their clinical and 
laboratory data were extracted from the patient database. CIE was defined as 
erythroderma without any apparent cause and lasting more than 3 months.  
Results: Twenty-three CIE, 82 AD, 39 psoriatic erythroderma and 99 drug eruption 
cases were enrolled. The mean age of CIE patients was 74.7±8.8, and the male:female 
ratio was 21:2. Laboratory data for CIE and AD were similar, but serum levels of 
thymus and activation-regulated chemokine (TARC), a T helper (Th) 2 cytokine, in the 
CIE group were significantly more elevated than in the AD group. Conversely, serum 
immunoglobulin (Ig) E levels were significantly lower in CIE patients compared with 
the atopic dermatitis group, and the ROC curve of the TARC/IgE ratio (7.24) provided 
efficient differentiation of the CIE group from AD patients. About PsE and DE, 
significant elevation of c-reactive protein was observed. Aspartate 
aminotransferase and alanine aminotransferase were also elevated in DE. 
Conclusions: CIE is an independent condition which is likely to occur in elderly men. 
Immunity is shifted to the Th2 type in CIE, however, the mechanism may differ from 
that of atopic dermatitis. 
 
Introduction 
Erythroderma is characterized by diffuse erythema of the skin accompanied by a 
variable degree of scaling involving over 90% of the body surface. 
Various diseases cause erythroderma, including eczema, atopic dermatitis, psoriasis, 
rashes induced by drugs or viral infection, Sezary syndrome and cutaneous lymphomas 
such as mycosis fungoides. However, dermatologists often encounter erythrodermic 
cases of unknown etiology and, in approximately 30% of erythroderma patients, there is 
no underlying cause 
1
. Papuloerythroderma of Ofuji is a representative erythroderma of 
unknown cause often seen in elderly men
2-5
. It exhibits the characteristic clinical finding 
that papules and erythema fuse and expand to involve the whole body and become 
erythrodermic, but the erythema avoids skin folds, the so-called “deck chair sign”. 
However, patients with erythroderma of unknown cause do not necessarily conform to 
this clinical manifestation. 
Typically, such idiopathic erythroderma is frequently seen in elderly men. However, we 
do not know whether this senile erythroderma represents an independent disease entity. 
In previous studies
1,3
, senile erythroderma patients were shown to have elevated levels 
of serum immunoglobulin (Ig) E and thymus and activation-regulated chemokine 
(TARC). Patients with atopic dermatitis (AD) are also well known to have elevated IgE 
and TARC
6
. These common findings provoke the question of whether the 
pathophysiology of senile erythroderma is similar to AD. 
To examine whether senile erythroderma is an independent entity, we compared 
clinical/biochemical characteristics of diseases that cause erythroderma, namely typical 
AD, psoriatic erythroderma (PsE), generalized drug eruption (DE). 
 
Methods 
Patients 
This was a retrospective cross-sectional study. Among patients who visited the 
Department of Dermatology, Fukuoka University Hospital between January 2010 and 
December 2015, clinical data for those diagnosed as having erythroderma were 
extracted from the patient database. Medical records of patients were manually checked 
and those whose erythroderma continued for more than 3 months without any known 
cause were designated as suffering from chronic idiopathic erythroderma (CIE). Patients 
with obvious evidence of cutaneous lymphoma (adult T-cell lymphoma, mycosis 
fungoides, Sezary’s syndrome or anaplastic large cell lymphoma) were excluded. 
Patients with a medical history of AD, or with obvious eczema lesions were also 
excluded from the CIE group. 
 
To outline the characteristics of CIE, patients with adult AD, PsE and DE were included 
as controls. For each disease, clinical data of patients older than 18 years were extracted 
in a similar manner from the database, and the diagnosis was confirmed manually by 
referring to the medical record. Patients with AD were enrolled only with a clinically 
typical manifestation that fulfills the criteria of Hanifin and Rajka, and with blood test 
results. Patients with PsE were diagnosed by clinical manifestation and 
histopathological examination. For DE, patients with toxic epidermolytic necrolysis and 
Stevens–Johnson syndrome were excluded, and we enrolled only patients with clinical 
manifestations of the disseminated papulo-erythematous type of DE, confirmed by 
histopathological examination.  
 
Blood tests 
Data describing hematologic and biochemical tests undertaken at the patients’ first visit 
were used.  
 
Statistical analysis  
Statistical analysis was carried out using SPSS. For comparisons between two groups, 
Student's t test was used for continuous changes and the Mann–Whitney U test was 
applied for non-parametric variables. The significance level was set at p<0.05. 
Correlations between variables were analyzed by Spearman's rank correlation analysis. 
A correlation coefficient, r, of less than 0.2 was considered as no correlation, 0.2–0.4 as 
a weak correlation, 0.4–0.6 as moderate, 0.6–0.8 as strong, and 0.8 or greater as an 
extremely strong correlation. This research was approved by the ethical committee of 
Fukuoka University School of Medicine. 
 
Results 
Profiles of patients (Table 1) 
There were 23 patients (21 men, two women, male/female ratio=10.5) in the CIE group. 
The mean age of CIE patients was 74.7 years old. Complications of malignant tumors 
were found in seven of 23 CIE patients (30.4%), all of which were men. There was one 
case with a history of gastric cancer that was completely resected without recurrence, 
two cases of completely resected colorectal cancer without recurrence, one case with 
colorectal cancer whose erythroderma was improved after surgical removal of the 
cancer, one case with a history of both gastric and esophageal cancers that were 
successfully treated, one case with a renal pelvis carcinoma and a past history of both 
gastric and esophageal cancer, and one case with a well-differentiated liposarcoma and a 
history of colon cancer. With respect to clinical manifestation, erythema that avoided 
skin folds of the abdomen, axilla and popliteal fossa was observed in eight of the 23 
patients (34.8%), which is a characteristic manifestation of papuloerythroderma known 
as the deck chair sign. 
 
Among the controls, there were 82 subjects (53 men, 29 women) in the AD group, 39 
(29 men, 10 women) in the PsE group, and 99 in the DE group (51 men, 48 women). 
The male/female ratio was clearly higher in the CIE group than in the AD and DE 
groups (p=0.018, p<0.001 respectively, using Fisher's exact test), but there was no 
significant difference between the CIE and PsE groups (p=0.182, Fisher's exact test). 
The mean age of subjects in the CIE group was significantly higher than in the AD, PsE 
and DE groups combined (p<0.001). Thus, CIE developed more frequently in elderly 
men. 
 
Blood test results (Table 2) 
Next, we compared the hematological and biochemical findings between the groups. 
There was no significant difference in the mean white blood cell count of the CIE group 
compared with the AD and PsE groups (p=0.367 and p=0.428, respectively), but the 
count was higher compared with the DE group (p=0.008). The eosinophil count was 
highest in CIE (1088±926), and was significantly higher than that in PsE and DE groups 
(p=0.002 for both comparisons), but was not significantly different from that in AD 
patients (p=0.108). 
 
Aspartate aminotransferase and alanine aminotransferase levels were highest in the DE 
group (33.5±31.7 IU/L and 35.9±44.3 IU/L, respectively), and were significantly higher 
than those of the CIE group (p=0.007 and p=0.012, respectively). Lactate 
dehydrogenase (LDH) was highest in CIE patients (309.1±82.8 IU/L), and was 
significantly higher than in the PsE and DE groups (p=0.027 and p=0.04, respectively), 
but not significantly different from AD patients (p=0.314).  
 
The mean C-reactive protein (CRP) level was higher in the PsE (2.90±5.40 mg/dL) and 
DE groups (2.49±3.87 mg/dL), but was only slightly increased in the CIE (0.67±1.11 
mg/dL) and AD groups (0.71±1.98 mg/dL). The mean CRP value was significantly 
lower in the CIE group compared with the PsE (p=0.03) and DE groups (p<0.001), and 
there was no significant difference compared with AD patients (p=0.932).  
 
Serum IgE levels were highest in the AD group (10,000±14,820 IU/mL). The IgE 
values of the CIE group were significantly lower than those of the AD group (p<0.001), 
and there was no significant difference compared with the PsE and DE groups (p=0.806, 
0.239 respectively).  
 
The mean TARC level was highest in the CIE group (15888±15344 pg/ml) and was 
significantly higher than in the AD group (p=0.008), but there was no significant 
difference compared with the PsE and DE groups (p=0.42 and p=0.296, respectively) 
due to the limited number of samples.  
 
From the results shown in Table 2, only IgE and TARC levels were significantly 
different between AD and CIE patients. A moderate correlation between IgE and TARC 
was observed in the AD group (r=0.592, p<0.001). Conversely, there was no significant 
correlation between IgE and TARC in the CIE group (r=0.415, p=0.124). When the 
IgE–TARC relationships in the CIE and AD groups were plotted on a graph, the CIE 
patients clustered in a low IgE–high TARC area compared with the AD patients (Fig. 1). 
Because the TARC/IgE (T/E) ratio of AD and CIE was different, we used this ratio as a 
distinction marker for CIE. The ROC curve of the T/E ratio (Fig. 2) showed an area 
under the curve of 0.918 (standard error=0.042, 95% confidential interval 0.834–1.000). 
We determined the cut-off value as the point closest to 1-specificity of 0 and sensitivity 
of 1 on the ROC curve. The T/E ratio could successfully distinguish CIE from AD with 
a sensitivity of 80% and specificity of 95% when the T/E ratio was >7.24.  
 
Discussion 
 
Adult AD is considered to be an important disease for the differential diagnosis of CIE. 
AD is a chronic dermatitis which is frequent in children, accompanied by deterioration 
of epidermal barrier function, and characteristically associated with increases in serum 
IgE and TARC levels
6
. The pathogenesis of AD is thought to involve a patient's 
immunity shifting to the Th2 type, and patients with AD often have allergic diseases 
such as asthma and allergic rhinitis
7
. It is considered that AD is most common in 
children and prevalence decreases in adults, with many cases of natural remission. We 
selected typical adult AD patients with a history from childhood as one of the 
comparator disease groups for CIE.  
 
TARC (also known as chemokine (C-C motif) ligand 17) is a cytokine produced by 
cells such as keratinocytes, dendritic cells, vascular endothelial cells and platelets 6. In 
particular, TARC is produced by dermal dendritic cells following stimulation by thymic 
stromal lymphopoietin, and causes Th2 cells to migrate to the skin 8. Serum levels of 
TARC closely reflect the severity of AD, and rise when AD is exacerbated 6. 3 On the 
other hand, IgE is an immunoglobulin involved in type 1 allergic reactions. 
Antigen-specific IgE binds to mast cells and basophils, inducing them to release 
mediators such as histamine in response to antigen stimulation. In a report of 169 AD 
patients followed for 4 years 9, a lower frequency of improved subjects (14.3%) was 
seen in a group with high IgE (>10,000 IU/mL), whereas a higher frequency (79.7%) 
was seen in a low IgE group (<1,000 IU / mL). 
 
We observed that IgE and TARC were elevated in patients of both CIE and AD groups, 
as previously reported
1
. However, the relationship between IgE and TARC was different 
in the two diseases, and the T/E ratio (>7.24) efficiently differentiated CIE from AD. 
This observation has not been previously reported, and may prove that the two 
conditions are indeed independent of one another. One possibility remains that the 
T/E ratio is dependent on age. Because CIE occurs almost exclusively to the 
elderly men as one of the important feature of the disease, we could not 
compare data in the same age groups. When we analyzed the correlation 
between age and IgE, TARC, and T/E ratio in patients with AD, we found no 
correlation between age and IgE (r = - 0.15, p = 0.179), age and TARC (r = 
0.092, p = 0.416), however, T/E ratio showed minimal correlation with age (r 
= 0.236, p = 0.035). Therefore, age could be one of the factors that cause a 
difference. However, the T/E ratio of AD and CIE differed greatly, so we 
assume that characteristics of the disease cause the difference rather than 
age. 
 
The mechanism leading to the observed difference between CIE and AD T/E ratio is not 
yet understood. One clue is that many AD patients have barrier abnormalities in the 
skin
10
, which eventually leads to IgE production against exogenous environmental 
antigens
11
. Inherent barrier abnormalities are unlikely in CIE, so erythroderma may be 
occurring endogenously. In the elderly, the number of induced regulatory T cells 
decreases with age, which may lead to low-grade and chronic inflammation
12
. 
 
Another reason for endogenous erythroderma may be the tumor-bearing condition of the 
patients. Several patients with erythroderma complicated by a malignant tumor have 
been reported 
4
, and erythroderma has become recognized as a dermadrome that is 
associated with tumors. In our CIE group, seven of 23 patients (30.4%) had cancer 
complications. However, the average age of patients in the CIE group was 75 years old, 
therefore, it was undetermined whether this rate of cancer was particularly high. There 
are many cases in which there is no longitudinal correlation between the time of cancer 
diagnosis and the time of onset of erythroderma, so it cannot be asserted that a 
malignant tumor is the cause of the erythroderma. 
 
In the CIE patients, LDH was correlated with TARC (r=0.539, p=0.026). Therefore, in 
CIE, similar to AD, we infer that LDH is released from keratinocytes in response to 
chronic dermatitis. Also, the CRP levels of patients with CIE were not elevated, while 
those of PsE and DE patients were increased. Patients with psoriasis commonly have 
chronically elevated CRP 
13,14
, and in psoriatic arthritis, CRP becomes higher 
13
. With 
DE, the effects of the original disease for which the drugs were administered, or 
drug-induced hepatitis may be responsible for the elevated CRP levels.  
 
In summary, we found that 1) Patients in the CIE group were mostly elderly men of 
significantly greater age than patients in the other groups; 2) The biochemical data 
indicates that IgE and TARC were elevated in both the CIE and AD groups. 
Furthermore, these two groups both had lower CRP and higher LDH compared with the 
PsE and DE patient groups; 3) In the CIE group, serum IgE was not elevated to the 
same extent as in AD patients, but conversely, TARC was higher. IgE and TARC 
correlated well in the AD group; however, this correlation was not seen in the CIE 
group. The ROC curve of the T/E ratio suggests that CIE can be distinguished from AD 
with a sensitivity of 80% and specificity of 95% when the T/E ratio is >7.24.  
 
Limitations of this study are the relatively small sample size and that it was undertaken 
in a single facility. Blood biochemical examinations were not performed in all cases. In 
some patients, treatment had already been started in other medical institutions. Ages of 
patient groups were different, which may have affected the biochemical results. 
 
We conclude that CIE is a condition likely to occur in elderly men, and shows a high 
T/E ratio profile distinct from AD patients. In the future, further research is necessary 
that incorporates larger sample sizes and evaluation of a wider panel of cytokines in 
addition to TARC. 
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Figure legends 
 
Fig. 1. Correlation between IgE and TARC in CIE and AD. IgE, immunoglobulin E; 
TARC, thymus and activation-regulated chemokine; CIE, chronic idiopathic 
erythroderma; AD, atopic dermatitis. 
 
Fig. 2. ROC curve of TARC/IgE ratio which distinguishes CIE from AD. Cut-off value 
of 7.24 provides sensitivity of 80% and specificity of 95%. IgE, immunoglobulin E; 
TARC, thymus and activation-regulated chemokine; CIE, chronic idiopathic 
erythroderma; AD, atopic dermatitis. 
 
  
Table 1. Patients’ backgrounds. 
 
CIE, chronic idiopathic erythroderma; AD, atopic dermatitis; PsE, psoriatic 
erythroderma; DE, drug eruption; SD, standard deviation. 
 
Table 2. Results of blood tests. 
 
 CIE  AD  PsE  DE  
 Mean n Mean n Mean n Mean n 
WBC /μl 8600±2800 23 8100±2400 80 9300±3800 37 6700±3100 98 
Eosinohphils /μl 1088±926 22 811±637 78 338±687 33 358±525 90 
AST IU/l 24.1±5.1 23 24.6±11.2 73 28.1±19.0 37 33.5±31.7 93 
ALT IU/l 22.8±10.7 23 26.2±24.1 73 22.8±11.1 37 35.9±44.3 93 
LDH IU/l 309.1±82.8 23 286.0±99.1 74 254.4±95.0 37 254.1±120.0 92 
CRP mg/dl 0.67±1.11 21 0.71±1.98 56 2.90±5.40 32 2.49±3.87 89 
IgE IU/ml 2374±4983 17 10000±14820 82 2009±2039 13 829±1712 19 
TARC pg/ml 15888±15344 17 4420±6990 80 9735±16936 6 9222±16275 10 
 
All data are shown as mean ± standard deviation. CIE, chronic idiopathic erythroderma; 
AD, atopic dermatitis; PsE, psoriatic erythroderma; DE, drug eruption; WBC, white 
blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, 
lactate dehydrogenase; CRP, C-reactive protein; IgE, immunoglobulin E; TARC, 
thymus and activation-regulated chemokine. 
Disease groups CIE AD PsE DE 
Numbers 23 82 39 99 
men/women 21/2 53/29 29/10 51/48 
Mean age±SD 74.7±8.8 33.0±14.5 57.5±14.2 64.5±14.9 
Body mass index 21.7±2.6 23.0±4.0 23.8±3.8 21.7±4.4 
 
